Catalyst Wire Dossier Catalyst Wire Dossier

Arthrotec

diclofenac sodium and misoprostol · Mylan Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Arthrotec, covering 2021-04-28 to 2021-04-28. Get the full timeline:

Most recent: FDA Approved: DICLOFENAC SODIUM AND MISOPROSTOL — Supplemental Application (Mylan Pharmaceuticals Inc.)

See pricing